Viralytics secures key EU patent
29-Oct-2008
- Australia
Professor Darren Shafren, Chief Scientist for Viralytics and inventor of the technology said, “The patent is similar to the patent granted in the United States of America in April 2008 covering the company’s core technology. Together, these patents give the company a strong intellectual property foundation for potential out-licensing and commercialization of our products and technology.”
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.